Latest Breaking News On - Company contact person - Page 5 : comparemela.com

Can Fite BioPharma : 20F FOR 2023 -March 28, 2024 at 09:47 am EDT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 20-F ☐.

United statesRamat ganTel avivMotti farbsteinInternational financial reporting standardsParty transactionsExchange commissionLeiden universityNational institute of healthInternational accounting standards boardTel aviv stock exchangeIsraeli limited companyCommission file noCompany contact personFite biopharma ltdAudit committee financial expert

BrainsWay : Report of Periodic or Interim Report -March 28, 2024 at 07:07 pm EDT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F .

United statesIsrael generalState of israelNexstim yingchiIdo maromHar hahotzvimInternational accounting standards boardSecurities exchangeCompany contact person securitiesUs veterans affairsInternational financial reporting standardsBrainsway ltdIsrael innovation authorityBynet buildingCompany contact personDepositary shares

AudioCodes : Other Report or Announcement -March 27, 2024 at 01:17 pm EDT

AudioCodes : Other Report or Announcement -March 27, 2024 at 01:17 pm EDT
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesRed seaDjibouti generalGaza stripWest bankBroadsoft broadworksShabtai adlersbergSecurities exchangeRibbon communicationsHp incContact centerAudiocodes ltdInternational financial reporting standardsIsraeli ministry of healthCompany contact personInternational accounting standards board

NICE : Immediate Report -March 27, 2024 at 06:17 pm EDT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F .

United statesUnited kingdomState of israelCompany contact personAudit committee financial expertService ccaaSecurities exchangeDevelopment of the companyInternational accounting standards boardService paaParty transactionsGrowth companyService ucaaExchange commissionInternational financial reporting standardsGeneral counsel

BioLineRx : Annual Report on Form 20-F FOR 2023 -March 26, 2024 at 08:40 am EDT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F .

United statesIsrael generalPhilipa serlinCompany american depositaryBiolinerx ltdIsrael companies lawInternational accounting standards boardInternational financial reporting standardsCompany contact personSecurities exchangeExchange commissionCompanies lawMark oneSecurities exchange actMa ayan street modi inDepositary shares